1Du X,Williams DA. Interleukin-11: review of molecular, cell biology, and clinical use. Blood, 1997, 89: 3897-3908. 被引量：1
2Kaviani MD, Mason LE, Bree AG, et al. Effects of recombinant human interleukin 11 on the activation and morphology of peripheral blood platelets and megakaryocytes in nonhuman primates. Blood,1996,88 (suppl 1):26-29. 被引量：1
3Bruno E,Briddell R, Cooper R, et al. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol, 1991, 19: 378-381. 被引量：1
4Weich NS, Wang A, Fitzgerald M, et al. Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood, 1997, 90:3893-3902. 被引量：1
5Tepler I, Elias L, Smith JW 2nd, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy . Blood, 1996, 87: 3607-3614. 被引量：1
6Gordon MS, McCaskill-Stevens WJ, Battiato LA, et al. A phase I trial of recombinant human interleukin-11(neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood, 1996, 87: 3615-3624. 被引量：1
7Isaacs C, Robert NJ, Bailey FA, et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. J Clin Oncol, 1997, 15: 3368-3377. 被引量：1
